5-Hydroxyindole causes convulsions and increases transmitter release in the CA1 region of the rat hippocampus

British Journal of Pharmacology

Volumn 138, Issue 1, 2003, Pages 245-253

  Mannaioni, Guido ^a   Carpenedo, Raffaella ^b   Moroni, Flavio ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

5 hydroxyindole; CA1; GABA; Glutamate; Hepatic encephalopathy; NAChR; Synaptic transmission

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 5 HYDROXYINDOLE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; N METHYL DEXTRO ASPARTIC ACID; TETRODOTOXIN; TROPISETRON;

AFTERHYPERPOLARIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; CONVULSION; EPILEPTOGENESIS; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC SYSTEM; HEPATIC ENCEPHALOPATHY; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SYNAPTIC TRANSMISSION;

ACTION POTENTIALS; ANIMALS; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; INDOLES; MALE; NEUROTRANSMITTER AGENTS; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; SEIZURES;

EID: 0037278486     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705007     Document Type: Article

References (42)

1. ALBRECHT, J. & JONES, E.A. (1999). Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J. Neurol. Sci., 170, 138-146.
2. ALKONDON, M., PEREIRA, E.F., BARBOSA, C.T. & ALBUQUERQUE, E.X. (1997). Neuronal nicotinic acetylcholine receptor activation modulates gamma-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J. Pharmacol. Exp. Ther., 283, 1396-1411.
3. BERQVIST, P.B.F., CARPENEDO, R., APELQVISI, G., MORONI, F. & BENGTSSON, F. (1999). Plasma and brain levels of oxindole in experimental chronic hepatic encephalopathy: effects of systemic ammonium acetate and L-tryptophan. Pharmacol. Toxicol., 85, 138-143.
4. BUONOMANO, D.V. & MERZENICH, M.M. (1998). Net interaction between different forms of short-term synaptic plasticity and slow-IPSPs in the hippocampus and auditory cortex. J. Neurophysiol., 80, 1765-1774.
5. BUTTERWORTH, R.F. (2001). Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings. Metab. Brain Dis., 16, 55-65.
6. CARPENEDO, R., CARLÀ, V., MONETI, G., CHIARUGI, A. & MORONI, F. (1997). Identification and measurement of oxindole (2-indolinone) in the mammalian brain and other rat organs. Analyt. Biochem., 244, 74-79.
7. CARPENEDO, R., CHIARUGI, A., RUSSI, P., LOMBARDI, G., CARLÀ, V., PELLICCIARI, R., MATTOLI, L. & MORONI, F. (1994). Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenic acid and have sedative and anticonvulsant activities. Neuroscience, 61, 237-244.
8. CARPENEDO, R., MANNAIONI, G. & MORONI, F. (1998). Oxindole, a sedative tryptophan metabolite, accumulates in blood and brain of rats with acute hepatic failure. J. Neurochem., 70, 1998-2003.
9. COLLINGRIDGE, G.L., KEHL, S.J. & McLENNAN, H. (1983). Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J. Physiol., 334, 33-46.
10. COZZI, A., ATTUCCI, S., PERUGINELLI, F., MARINOZZI, M., LUNEIA, R., PELLICCIARI, R. & MORONI, F. (1997). Type 2 metabotropic glutamate (mGlu) receptors tonically inhibit transmitter release in rat caudate nucleus: in vivo studies with (2S, 1′S, 2′S, 3′R)-2-(2′-carboxy-3′-phenylcyclopropyl)glycine, a new potent and selective antagonist. Eur. J. Neurosci., 9, 1350-1355.
11. DOBELIS, P., MADL, J.E., PFISTER, J.A., MANNERS, G.D. & WALROND, J.P. (1999). Effects of Delphinium alkaloids on neuromuscular transmission. J. Pharmacol. Exp. Ther., 291, 538-546.
12. FISHER, J.L., PIDOPLICHKO, V.I. & DANI, J.A. (1998). Nicotine modifies the activity of ventral tegmental area dopaminergic neurons and hippocampal GABAergic neurons. J. Physiol. (Paris), 92, 209-213.
13. GAMMAL, S.H., BASILE, A.S., GELLER, D., SKOLNICK, P. & JONES, E.A. (1990). Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology, 11, 371-378.
14. 7 subtype. Soc. Neurosci., 26 (Abst) 1916.
15. HARRISON, N.L & SIMMONDS, M.A. (1985). Quantitative studies of some antagonists of NMDA in slices of rat cerebral cortex. Br. J. Pharmacol., 84, 381-391.
16. KING, L.J., PARKE, D.V. & WILLIAMS, R.T. (1966). The metabolism of [2-14C] indole in the rat. Biochem. J., 98, 266-277.
17. KOOYMAN, A.R., VAN HOOFT, J.A., VANDERHEIJDEN, P.M. & VIJVERBERG, H.P. (1994). Competitive and non-competitive effects of 5-hydroxyindole on 5-HT3 receptors in N1E-115 neuroblastoma cells. Br. J. Pharmacol., 112, 541-546.
18. KOOYMAN, A.R., VAN HOOFT, J.A. & VIJVERBERG, H.P. (1993). 5-Hydroxyindole slows desensitization of the 5-HT3 receptor-mediated ion current in N1E-115 neuroblastoma cells. Br. J. Pharmacol., 108, 287-289.
19. LENA, C., CHANGEUX, J.P. & MULLE, C. (1993). Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J. Neurosci., 13, 2680-2688.
20. LYNCH, G. & SCHUBERT, P. (1980). The use of in vitro brain slices for multidisciplinary studies of synaptic function. Annu. Rev. Neurosci., 3, 1-22.
21. MACCAFERRI, G., ROBERTS, J.D., SZUCS, P., COTTINGHAM, C.A. & SOMOGYI, P. (2000). Cell surface domain specific postsynaptic currents evoked by identified GABAergic neurones in rat hippocampus in vitro. J. Physiol., 524, 91-116.
22. MANNAIONI, G., ALESIANI, M., CARLÀ, V., NATALINI, B., MARINOZZI, M., PELLICCIARI, R. & MORONI, F. (1994). Sulfate esters of hydroxy amino acids as stereospecific glutamate receptor agonists. Eur. J. Pharmacol., 251, 201-207.
23. MANNAIONI, G., CARLÀ, V. & MORONI, F. (1996). Pharmacological characterization of metabotropic glutamate receptors potentiating NMDA responses in mouse cortical wedge preparations. Br. J. Pharmacol., 118, 1530-1536.
24. MANNAIONI, G., CARPENEDO, R., CORRADETTI, R., CARLÀ, V., VENTURINI, I., BARALDI, M., ZENEROLI, M.L. & MORONI, F. (1999). Tryptophan metabolism and hepatic encephalopathy. Studies on the sedative properties of oxindole. Adv. Exp. Med. Biol., 467, 155-167.
25. MANNAIONI, G., CARPENEDO, R., PUGLIESE, A.M., CORRADETTI, R. & MORONI, F. (1998). Electrophysiological studies on oxindole, a neurodepressant tryptophan metabolite. Br. J. Pharmacol., 125, 1751-1760.
26. MANSVELDER, H.D., KEATH, J.R. & MCGEHEE, D.S. (2002). Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron, 33, 905-919.
27. MORONI, F., CARPENEDO, R., MANNAIONI, G., GALLI, A., CHIARUGI, A., CARLÀ, V. & MONETI, G. (1997). Studies on the pharmacological properties of oxindole (2-hydroxyindole) and 5-hydroxyindole: are they involved in hepatic encephalopathy? In Advances in Cirrhosis, Hyperammoniemia, and Hepatic Encephalopathy. eds. Felipo, V. & Grisolia, S. pp. 57-73. New York: Plenum Press.
28. MORONI, F., CARPENEDO, R., VENTURINI, I., BARALDI, M. & ZENEROLI, M.L. (1998). Oxindole in pathogenesis of hepatic encephalopathy. Lancet, 351, 1861.
29. MORONI, F., LOMBARDI, G., MONETI, G. & CORTESINI, C. (1983). The release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J. Neurochem., 40, 850-854.
30. MORONI, F., MULAS, A., MONETI, G. & PEPEU, G. (1982). In vitro changes in gamma-aminobutyric acid output from the cerebral cortex induced by inhibitors of gamma-aminobutyric acid uptake and metabolism. J. Neurochem., 39, 582-584.
31. PASSANI, M.B., PUGLIESE, A.M., AZZURRINI, M. & CORRADETTI, R. (1994). Effects of DAU 6215, a novel 5-hydroxytryptamine3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus. Br. J. Pharmacol., 112, 695-703.
32. PEI, Q., ZETTERSTROM, T., LESLIE, R.A. & GRAHAME-SMITH, D.G. (1993). 5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat. Eur. J. Pharmacol., 230, 63-68.
33. PELLEGRINI-GIAMPIETRO, D.E., CHERICI, G., ALESIANI, M., CARLÀ, V. & MORONI, F. (1988). Excitatory amino acid release from rat hippocampal slices as a consequence of free radical formation. J. Neurochem., 51, 1960-1963.
34. PELLEGRINI-GIAMPIETRO, D.E., CHERICI, G., ALESIANI, M., CARLÀ, V. & MORONI, F. (1990). Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J. Neurosci., 10, 1035-1041.
35. RACINE, R.J. (1972). Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol., 32, 281-294.
36. RADCLIFFE, K.A., FISHER, J.L., GRAY, R. & DANI, J.A. (1999). Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons. Ann. N.Y. Acad. Sci., 868, 591-610.
37. ROPERT, N. & GUY, N. (1991). Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro. J. Physiol., 441, 121-136.
38. ROPERT, N., MILES, R. & KORN, H. (1990). Characteristics of miniature inhibitory postsynaptic currents in CA1 pyramidal neurones of rat hippocampus. J. Physiol., 428, 707-722.
39. SAH, P., HESTRIN, S. & NICOLL, R.A. (1989). Tonic activation of NMDA receptors by ambient glutamate enhances excitability of neurons. Science, 246, 815-818.
40. SOLIS, J.M. & NICOLL, R.A. (1992). Pharmacological characterization of GABAB-mediated responses in the CA1 region of the rat hippocampal slice. J. Neurosci., 12, 3466-3472.
41. WONNACOTT, S. (1997). Presynaptic nicotinic ACh receptors. Trends Neurosci., 20, 92-98.
42. ZENEROLI, M.L. & BARALDI, M. (1990). Neurotransmission in hepatic encephalopathy. Adv. Exp. Med. Biol., 272, 135-148.